Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
1.460
-0.080 (-5.19%)
Dec 5, 2025, 4:00 PM EST - Market closed
Prelude Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -111.77 | -127.17 | -121.83 | -115.44 | -111.69 | -56.93 | |
| Depreciation & Amortization | 1.78 | 1.77 | 1.17 | 1.32 | 0.92 | 0.54 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.01 | |
| Loss (Gain) From Sale of Investments | -1.13 | -4.64 | -3.47 | 2.59 | 1.36 | - | |
| Stock-Based Compensation | 13.84 | 21.35 | 25.62 | 25.14 | 20.93 | 5.58 | |
| Other Operating Activities | 1.54 | 1.59 | 1.94 | 1.72 | 1.33 | - | |
| Change in Accounts Payable | -3.38 | 3.31 | -2.27 | -0.35 | 3.9 | 1.16 | |
| Change in Other Net Operating Assets | -1.04 | 0.91 | -8.21 | 1.28 | -0.28 | 3.46 | |
| Operating Cash Flow | -100.17 | -102.89 | -107.06 | -83.73 | -83.53 | -46.18 | |
| Capital Expenditures | -0.12 | -0.76 | -3.51 | -3.02 | -2.32 | -0.62 | |
| Investment in Securities | 136.04 | 90.96 | -31.13 | 84.71 | -261.48 | - | |
| Investing Cash Flow | 135.92 | 90.19 | -34.65 | 81.69 | -263.8 | -0.62 | |
| Long-Term Debt Repaid | - | -0.4 | - | - | - | -0.26 | |
| Net Debt Issued (Repaid) | -0.36 | -0.4 | - | - | - | -0.26 | |
| Issuance of Common Stock | 0.22 | 0.44 | 136.41 | 0.82 | 165.2 | 166.73 | |
| Repurchase of Common Stock | -0.02 | -0.05 | -0.02 | - | - | - | |
| Other Financing Activities | - | -0.11 | - | - | -0.3 | -0.01 | |
| Financing Cash Flow | -0.16 | -0.12 | 136.4 | 0.82 | 164.9 | 246.23 | |
| Net Cash Flow | 35.59 | -12.82 | -5.31 | -1.22 | -182.44 | 199.43 | |
| Free Cash Flow | -100.29 | -103.65 | -110.58 | -86.75 | -85.85 | -46.8 | |
| Free Cash Flow Margin | -955.10% | -1480.74% | - | - | - | - | |
| Free Cash Flow Per Share | -1.32 | -1.37 | -1.83 | -1.83 | -1.86 | -3.75 | |
| Levered Free Cash Flow | -64.8 | -62 | -58.93 | -50.12 | -46.86 | -25.58 | |
| Unlevered Free Cash Flow | -64.8 | -62 | -58.93 | -50.12 | -46.86 | -25.58 | |
| Change in Working Capital | -4.42 | 4.22 | -10.48 | 0.93 | 3.63 | 4.62 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.